| |
| |
|
| Insider
Information: |
Brumm Joshua T |
| Relationship: |
|
| City: |
Pleasanton |
| State: |
CA |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
3 |
|
| Direct
Shares |
746,959 |
|
|
Indirect Shares
|
0 |
|
|
| Direct
Value |
$18,133,224 |
|
|
|
Indirect Value
|
$0 |
|
|
| Total
Shares |
746,959 |
|
|
| Total
Value |
$18,133,224 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
5
|
|
Stock
price went up :
|
0
|
3
|
| Stock
price went down : |
0
|
2
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
1.5
|
| Percentage
Gain/Loss : |
0.0%
|
 267.7%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Zeltiq Aesthetics Inc |
ZLTQ |
VP of Corporate Develo... |
2012-02-17 |
7,692 |
2012-02-17 |
0 |
Premium* |
|
|
Aravive Inc |
ARAV |
COO and CFO |
2017-10-19 |
201,269 |
2014-04-15 |
0 |
Premium* |
|
|
Dyne Therapeutics, Inc. |
DYN |
|
2024-03-11 |
537,998 |
2020-09-17 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
25 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 1
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| DYN |
Dyne Therapeutics, Inc. |
CEO & President |
• • – |
2024-03-01 |
4 |
AS |
$28.25 |
$2,743,719 |
D/D |
(94,480) |
563,471 |
0 |
% |
|
| DYN |
Dyne Therapeutics, Inc. |
CEO & President |
• • – |
2024-02-29 |
4 |
AS |
$27.50 |
$151,800 |
D/D |
(5,520) |
563,471 |
0 |
% |
|
| DYN |
Dyne Therapeutics, Inc. |
CEO & President |
• • – |
2024-03-07 |
4 |
AS |
$25.85 |
$234,873 |
D/D |
(9,086) |
554,385 |
0 |
% |
|
| DYN |
Dyne Therapeutics, Inc. |
CEO & President |
• • – |
2024-03-11 |
4 |
AS |
$25.42 |
$1,704,142 |
D/D |
(66,387) |
537,998 |
0 |
% |
|
| DYN |
Dyne Therapeutics, Inc. |
CEO & President |
• • – |
2024-03-08 |
4 |
AS |
$25.30 |
$9,421,634 |
D/D |
(363,343) |
554,385 |
0 |
% |
|
| ARAV |
Aravive Inc |
COO and CFO |
• – – |
2017-02-24 |
4 |
AS |
$20.42 |
$628,063 |
D/D |
(30,000) |
105,779 |
0 |
- |
|
| DYN |
Dyne Therapeutics, Inc. |
CEO & President |
• – – |
2024-01-04 |
4 |
AS |
$18.40 |
$4,045,958 |
D/D |
(218,536) |
584,971 |
0 |
% |
|
| DYN |
Dyne Therapeutics, Inc. |
CEO & President |
• – – |
2024-01-03 |
4 |
AS |
$18.34 |
$986,957 |
D/D |
(51,183) |
584,971 |
0 |
% |
|
| ARAV |
Aravive Inc |
COO and CFO |
• – – |
2017-05-16 |
4 |
S |
$17.40 |
$21,976 |
D/D |
(1,263) |
107,016 |
0 |
- |
|
| ARAV |
Aravive Inc |
Chief Financial Officer |
• – – |
2015-06-11 |
4 |
D |
$17.28 |
$48,078 |
D/D |
(2,597) |
34,038 |
0 |
- |
|
| DYN |
Dyne Therapeutics, Inc. |
See Remarks |
• • – |
2021-09-21 |
4 |
AS |
$16.11 |
$73,848 |
D/D |
(4,584) |
99,018 |
0 |
% |
|
| ARAV |
Aravive Inc |
COO and CFO |
• – – |
2017-06-13 |
4 |
S |
$16.05 |
$22,807 |
D/D |
(1,421) |
105,595 |
0 |
- |
|
| ARAV |
Aravive Inc |
Chief Financial Officer |
• – – |
2016-12-27 |
4 |
S |
$15.85 |
$15,692 |
D/D |
(990) |
64,824 |
0 |
- |
|
| DYN |
Dyne Therapeutics, Inc. |
See Remarks |
• • – |
2021-09-20 |
4 |
AS |
$15.61 |
$53,464 |
D/D |
(3,425) |
103,602 |
0 |
% |
|
| DYN |
Dyne Therapeutics, Inc. |
See Remarks |
• • – |
2022-09-15 |
4 |
D |
$14.05 |
$48,894 |
D/D |
(3,480) |
216,459 |
0 |
- |
|
| ARAV |
Aravive Inc |
COO and CFO |
• – – |
2017-01-30 |
4 |
S |
$13.85 |
$40,794 |
D/D |
(2,945) |
105,779 |
0 |
- |
|
| DYN |
Dyne Therapeutics, Inc. |
See Remarks |
• • – |
2022-09-20 |
4 |
D |
$13.70 |
$162,153 |
D/D |
(11,836) |
204,623 |
0 |
- |
|
| DYN |
Dyne Therapeutics, Inc. |
See Remarks |
• • – |
2022-10-07 |
4 |
S |
$13.37 |
$189,854 |
D/D |
(14,200) |
204,623 |
0 |
% |
|
| DYN |
Dyne Therapeutics, Inc. |
See Remarks |
• • – |
2023-06-09 |
4 |
S |
$13.34 |
$1,021,604 |
D/D |
(76,582) |
269,771 |
0 |
% |
|
| ARAV |
Aravive Inc |
Chief Financial Officer |
• – – |
2016-12-07 |
4 |
S |
$13.25 |
$40,028 |
D/D |
(3,021) |
65,814 |
0 |
- |
|
| DYN |
Dyne Therapeutics, Inc. |
See Remarks |
• • – |
2023-06-08 |
4 |
S |
$13.15 |
$806,690 |
D/D |
(61,000) |
269,771 |
0 |
% |
|
| DYN |
Dyne Therapeutics, Inc. |
See Remarks |
• • – |
2023-06-12 |
4 |
S |
$12.61 |
$2,367,502 |
D/D |
(187,748) |
253,383 |
0 |
% |
|
| DYN |
Dyne Therapeutics, Inc. |
See Remarks |
• • – |
2022-10-10 |
4 |
S |
$12.46 |
$2,439,668 |
D/D |
(195,800) |
204,623 |
0 |
% |
|
| ARAV |
Aravive Inc |
Chief Financial Officer |
• – – |
2015-12-30 |
4 |
S |
$12.44 |
$12,312 |
D/D |
(990) |
35,548 |
0 |
- |
|
| DYN |
Dyne Therapeutics, Inc. |
See Remarks |
• • – |
2022-12-12 |
4 |
AS |
$10.87 |
$36,110 |
D/D |
(3,322) |
329,801 |
0 |
% |
|
25 Records found
|
1
|
Page 1 of 1 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
